Direct cardiac versus systemic effects of inorganic nitrite on human left ventricular function.


Journal

American journal of physiology. Heart and circulatory physiology
ISSN: 1522-1539
Titre abrégé: Am J Physiol Heart Circ Physiol
Pays: United States
ID NLM: 100901228

Informations de publication

Date de publication:
01 07 2021
Historique:
pubmed: 22 5 2021
medline: 15 9 2021
entrez: 21 5 2021
Statut: ppublish

Résumé

Inorganic nitrite is a source of nitric oxide (NO) and is considered as a potential therapy in settings where endogenous NO bioactivity is reduced and left ventricular (LV) function impaired. However, the effects of nitrite on human cardiac contractile function, and the extent to which these are direct or indirect, are unclear. We studied 40 patients undergoing diagnostic cardiac catheterization who had normal LV systolic function and were not found to have obstructive coronary disease. They received either an intracoronary sodium nitrite infusion (8.7-26 µmol/min,

Identifiants

pubmed: 34018850
doi: 10.1152/ajpheart.00081.2021
pmc: PMC8505166
doi:

Substances chimiques

Sodium Nitrite M0KG633D4F

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

H175-H184

Subventions

Organisme : British Heart Foundation
ID : CH/1999001/11735
Pays : United Kingdom
Organisme : British Heart Foundation
ID : RE/18/2/34213
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/R017751/1
Pays : United Kingdom
Organisme : Department of Health
ID : IS-BRC-1215-20006
Pays : United Kingdom

Références

Nat Rev Drug Discov. 2008 Feb;7(2):156-67
pubmed: 18167491
Artery Res. 2013 Mar;7(1):
pubmed: 24179554
PLoS One. 2012;7(1):e30380
pubmed: 22276188
Free Radic Biol Med. 2013 Dec;65:1521-1532
pubmed: 23806384
Circulation. 2010 Feb 2;121(4):519-28
pubmed: 20083682
J Mol Cell Cardiol. 2019 Sep;134:40-50
pubmed: 31226341
Circulation. 2012 Aug 14;126(7):830-9
pubmed: 22806632
J Mol Cell Cardiol. 2009 Apr;46(4):490-8
pubmed: 19639676
Nat Rev Cardiol. 2014 Sep;11(9):507-15
pubmed: 24958077
Circulation. 2008 Feb 5;117(5):670-7
pubmed: 18212289
JAMA. 2018 Nov 6;320(17):1764-1773
pubmed: 30398602
Circ Res. 1994 May;74(5):970-8
pubmed: 8156644
Am J Physiol. 1994 Nov;267(5 Pt 2):H1804-13
pubmed: 7526713
N Engl J Med. 2015 Dec 10;373(24):2314-24
pubmed: 26549714
JACC Heart Fail. 2016 Jun;4(6):428-37
pubmed: 26874390
Circulation. 1995 Oct 15;92(8):2119-26
pubmed: 7554191
N Engl J Med. 2004 Nov 11;351(20):2049-57
pubmed: 15533851
Hypertension. 2017 Apr;69(4):633-640
pubmed: 28223475
Circ Res. 2010 Mar 5;106(4):633-46
pubmed: 20203313
J Am Coll Cardiol. 2018 Jan 23;71(3):363-364
pubmed: 29348029
JACC Cardiovasc Imaging. 2019 Jan;12(1):52-63
pubmed: 30448118
JCI Insight. 2016 Nov 3;1(18):e89620
pubmed: 27812547
Circ Res. 2015 Jan 30;116(3):437-47
pubmed: 25512434
Am J Physiol. 1994 May;266(5 Pt 2):H1699-705
pubmed: 8203569
J Appl Physiol (1985). 2016 Feb 15;120(4):416-25
pubmed: 26607249
Circ Res. 2007 Mar 16;100(5):654-61
pubmed: 17293481
Circulation. 2011 Dec 20;124(25):2882-91
pubmed: 22144574
Hypertension. 2010 Aug;56(2):274-81
pubmed: 20585108
Nat Med. 2003 Dec;9(12):1498-505
pubmed: 14595407
Physiol Rev. 2019 Jan 1;99(1):311-379
pubmed: 30379623
J Physiol. 2002 Apr 15;540(Pt 2):457-67
pubmed: 11956336
Circulation. 1997 Dec 2;96(11):3897-903
pubmed: 9403613
J Am Coll Cardiol. 2015 Oct 13;66(15):1672-82
pubmed: 26449137
Am J Physiol Heart Circ Physiol. 2006 Jul;291(1):H403-12
pubmed: 16428349
J Am Coll Cardiol. 2017 Jul 11;70(2):136-148
pubmed: 28683960
J Physiol. 2009 Oct 15;587(Pt 20):4977-86
pubmed: 19723781
Circ Res. 2009 Jan 2;104(1):87-94
pubmed: 19023132
Nat Rev Cardiol. 2018 May;15(5):292-316
pubmed: 29388567
Eur Heart J. 2014 May 14;35(19):1255-62
pubmed: 24639423
J Am Coll Cardiol. 2013 Jul 23;62(4):263-71
pubmed: 23684677
J Neurosurg. 2011 Dec;115(6):1213-20
pubmed: 21888479
Circulation. 1994 May;89(5):2070-8
pubmed: 7910117
Circulation. 2015 Jan 27;131(4):381-9; discussion 389
pubmed: 25533964
Circulation. 2007 Oct 16;116(16):1821-31
pubmed: 17893272

Auteurs

Kevin O'Gallagher (K)

Department of Cardiology, School of Cardiovascular Medicine & Sciences, King's College London British Heart Foundation Centre of Research Excellence, London, United Kingdom.
Department of Clinical Pharmacology, School of Cardiovascular Medicine & Sciences, King's College London British Heart Foundation Centre of Research Excellence, London, United Kingdom.

Ana R Cabaco (AR)

Department of Cardiology, School of Cardiovascular Medicine & Sciences, King's College London British Heart Foundation Centre of Research Excellence, London, United Kingdom.

Matthew Ryan (M)

Department of Cardiology, School of Cardiovascular Medicine & Sciences, King's College London British Heart Foundation Centre of Research Excellence, London, United Kingdom.

Ali Roomi (A)

Department of Cardiology, School of Cardiovascular Medicine & Sciences, King's College London British Heart Foundation Centre of Research Excellence, London, United Kingdom.

Haotian Gu (H)

Department of Clinical Pharmacology, School of Cardiovascular Medicine & Sciences, King's College London British Heart Foundation Centre of Research Excellence, London, United Kingdom.

Luke Dancy (L)

Department of Cardiology, School of Cardiovascular Medicine & Sciences, King's College London British Heart Foundation Centre of Research Excellence, London, United Kingdom.

Narbeh Melikian (N)

Department of Cardiology, School of Cardiovascular Medicine & Sciences, King's College London British Heart Foundation Centre of Research Excellence, London, United Kingdom.

Philip J Chowienczyk (PJ)

Department of Clinical Pharmacology, School of Cardiovascular Medicine & Sciences, King's College London British Heart Foundation Centre of Research Excellence, London, United Kingdom.

Andrew J Webb (AJ)

Department of Clinical Pharmacology, School of Cardiovascular Medicine & Sciences, King's College London British Heart Foundation Centre of Research Excellence, London, United Kingdom.

Ajay M Shah (AM)

Department of Cardiology, School of Cardiovascular Medicine & Sciences, King's College London British Heart Foundation Centre of Research Excellence, London, United Kingdom.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH